Loading…
A quadruple-blinded, placebo-controlled, randomized phase II treatment trial (Parallel Assignment) to evaluate PRIM-DJ2727 or placebo in patients with active Ulcerative Colitis (UC)
Patients in remission after administering 12 weeks of PRIM-DJ2727 capsules measured by partial Mayo score ≤ 3
No published results were found as of May 2026